isotretinoin 40mg capsules
icarus pharmaceuticals ltd - isotretinoin - oral capsule - 40mg
octaplex powder and solvent for solution for infusion
octapharma pharmazeutika produktionsges. m.b.h. - human blood coagulation factor ii, human blood coagulation factor vii, human blood coagulation factor ix, human blood coagulation factor x, protein c, protein s - powder and solvent for solution for infusion - 14-38iu/ml+ 9-24iu/ml+ 25iu/ml+ 18-30iu/ml+ 13-31iu/ml+ 12-32iu/ml
dalacin vaginal ovule
pharmacia limited - clindamycin phosphate - pessary - 100 milligram
avastin
roche products pty ltd - bevacizumab -
dbl meropenem for injection
hospira pty limited - meropenem trihydrate -
meropenem kabi
ranbaxy australia pty ltd - meropenem trihydrate -
meropenem ranbaxy
ranbaxy australia pty ltd - meropenem trihydrate -
meropenem sandoz
sandoz pty ltd - meropenem trihydrate -
ropenn
medis pharma pty ltd - meropenem trihydrate -
meropenem kabi meropenem (as trihydrate) 1 g powder for injection vials
fresenius kabi australia pty ltd - meropenem trihydrate, quantity: 1140 mg (equivalent: meropenem, qty 1000 mg) - injection, powder for - excipient ingredients: sodium carbonate - indications,meropenem kabi is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics:,? community acquired lower respiratory tract infection ,? hospital acquired lower respiratory tract infection,? complicated urinary tract infection,? febrile neutropaenia,? intra-abdominal and gynaecological (poly microbial) infections,? complicated skin and skin structure infections,? meningitis,? septicaemia